Rock Springs Capital Management LP Novo Cure LTD Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $3.2 Million - $4.27 Million	-50,000 Reduced 28.57%	125,000 $9.17 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $142,625 - $239,375	2,500 Added 1.45%	175,000 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $1.39 Million - $2.2 Million	-22,500 Reduced 11.54%	172,500 $12.9 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $4.88 Million - $8.95 Million	170,000 Added 680.0%	195,000 $6.53 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $800,000 - $1.31 Million	25,000 New	25,000 $1.31 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.